140 related articles for article (PubMed ID: 6555059)
1. Intratumoral BCG and Corynebacterium parvum therapy of canine mammary tumours before radical mastectomy.
Parodi AL; Misdorp W; Mialot JP; Mialot M; Hart AA; Hurtrel M; Salomon JC
Cancer Immunol Immunother; 1983; 15(3):172-7. PubMed ID: 6555059
[TBL] [Abstract][Full Text] [Related]
2. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
3. Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Dec; 38(12):4522-6. PubMed ID: 719637
[TBL] [Abstract][Full Text] [Related]
4. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
Fisher B; Gebhardt M; Linta J; Saffer E
Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
[No Abstract] [Full Text] [Related]
6. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Boyer CM; Purnell DM
Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
[TBL] [Abstract][Full Text] [Related]
8. Regression of a hamster melanoma with intralesional Corynebacterium granulosum.
Paslin D
Br J Dermatol; 1976 Jun; 94(6):639-44. PubMed ID: 949459
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study and survival analysis on bitches with mammary tumours spayed at the same time of mastectomy.
Banchi P; Morello EM; Bertero A; Ricci A; Rota A
Vet Comp Oncol; 2022 Mar; 20(1):172-178. PubMed ID: 34351034
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
[TBL] [Abstract][Full Text] [Related]
11. C. parvum treatment of transplanted rat tumours of spontaneous origin.
Willmott N; Pimm MV; Baldwin RW
Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514
[TBL] [Abstract][Full Text] [Related]
12. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
Greager JA; Baldwin RW
Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
[No Abstract] [Full Text] [Related]
13. Active experimental inhibition of cancer by corynebacterium parvum.
Wrba H; Dutter A
Osterr Z Onkol; 1977 Oct; 4(2-3):60-1. PubMed ID: 579449
[TBL] [Abstract][Full Text] [Related]
14. Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours.
Woodruff MF; Inchley MP; Dunbar N
Br J Cancer; 1972 Apr; 26(2):67-76. PubMed ID: 5038327
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of carcinoembryonic antigen in mammary neoplasms of bitches.
Senhorello ILS; Terra EM; Sueiro FAR; Firmo BF; Anai LA; Goloni C; Canavari IC; Ampuero RAN; Pereira RS; Tinucci-Costa M
Vet Comp Oncol; 2020 Sep; 18(3):315-323. PubMed ID: 31664787
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of postoperative metastases of 13762A rat mammary adenocarcinoma: comparative effectiveness of BCG substrains and methods of preparation.
Kreider JW; Bartlett GL; Purnell DM
Cancer; 1980 Aug; 46(3):500-7. PubMed ID: 7397623
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intratumoral immunostimulants in the treatment of a transplantable rat mammary carcinoma.
Willmott N; Austin EB; Pimm MV; Baldwin RW
Eur J Cancer (1965); 1981 Apr; 17(4):397-405. PubMed ID: 7308253
[No Abstract] [Full Text] [Related]
18. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation in treatment of mice with tumors.
Fisher B; Linta J; Hanlon J; Saffer E
J Natl Cancer Inst; 1978 Feb; 60(2):391-9. PubMed ID: 413929
[No Abstract] [Full Text] [Related]
19. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
Fisher B; Wolmark N; Saffer E; Fisher ER
Cancer; 1975 Jan; 35(1):134-43. PubMed ID: 1109767
[TBL] [Abstract][Full Text] [Related]
20. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW; Biro TG
Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]